"The Company has another license agreement with Pfizer Inc., for which revenue is being deferred. The Company recognized $1,300 in income for each of the three months ended February 28, 2014 and 2013. The balance of deferred revenue from this license is $19,500 and $20,800 at February 28, 2014 and November 30, 2013, respectively, and will be amortized into revenue through January 2018. "